13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 22 holding rows worth $109,726,000.
- Accession
- 0000950123-22-009121
- Filer
- CIK 1822947
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 22 entries on the cover page, a total value of $109,726,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $109,726,000 with VALUE read as thousands by filing date, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 39,370 | $14,917,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 5,894,897 | $9,019,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 857,352 | $7,733,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 115,000 | $7,593,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 160,000 | $6,454,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 650,000 | $6,253,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 700,000 | $5,859,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 496,012 | $5,739,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 181,500 | $4,498,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 170,000 | $4,495,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 250,000 | $4,373,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 1,137,152 | $3,684,000 | thousands by filing date | |
| ISOPLEXIS CORP | 465005106 | COM | 1,650,118 | $3,564,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 735,000 | $3,322,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 3,364,895 | $3,239,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 207,290 | $3,217,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 160,000 | $3,038,000 | thousands by filing date | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 699,664 | $3,009,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 1,080,566 | $2,907,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 1,410,155 | $2,834,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 175,000 | $2,312,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 550,000 | $1,667,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-009121 | this filing | 2022-08-15 | acceptance time not in the bulk data set |